Invalid Symbol

Stock Research for GENE

GENE
Current Price

$


Latest Update:

High
$
Low
$
Close
$
Volume
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

GENE Stock Chart & Research Data

The GENE chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GENE chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


GENE Due diligence Resources & Stock Charts

The GENE stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GENE Detailed Price Forecast - CNN Money CNN View GENE Detailed Summary - Google Finance
Yahoo View GENE Detailed Summary - Yahoo! Finance Zacks View GENE Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View GENE Trends & Analysis - Trade-Ideas Barrons View GENE Major Holders - Barrons
NASDAQ View GENE Call Transcripts - NASDAQ Seeking View GENE Breaking News & Analysis - Seeking Alpha
Spotlight View GENE Annual Report - CompanySpotlight.com OTC Report View GENE OTC Short Report - OTCShortReport.com
TradeKing View GENE Fundamentals - TradeKing Charts View GENE SEC Filings - Bar Chart
WSJ View Historical Prices for GENE - The WSJ Morningstar View Performance/Total Return for GENE - Morningstar
MarketWatch View the Analyst Estimates for GENE - MarketWatch CNBC View the Earnings History for GENE - CNBC
StockMarketWatch View the GENE Earnings - StockMarketWatch MacroAxis View GENE Buy or Sell Recommendations - MacroAxis
Bullish View the GENE Bullish Patterns - American Bulls Short Pains View GENE Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View GENE Stock Mentions - StockTwits PennyStocks View GENE Stock Mentions - PennyStockTweets
Twitter View GENE Stock Mentions - Twitter Invest Hub View GENE Investment Forum News - Investor Hub
Yahoo View GENE Stock Mentions - Yahoo! Message Board Seeking Alpha View GENE Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for GENE - SECform4.com Insider Cow View Insider Transactions for GENE - Insider Cow
CNBC View GENE Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GENE - OTC Markets
Yahoo View Insider Transactions for GENE - Yahoo! Finance NASDAQ View Institutional Holdings for GENE - NASDAQ


Stock Charts

FinViz View GENE Stock Insight & Charts - FinViz.com StockCharts View GENE Investment Charts - StockCharts.com
BarChart View GENE Stock Overview & Charts - BarChart Trading View View GENE User Generated Charts - Trading View


Latest Financial News for GENE

Genetic Technologies Announces Strategic Alliance and Capital Raising
Posted on Thursday February 15, 2018

MELBOURNE, Australia, Feb. 15, 2018-- Genetic Technologies Limited a molecular diagnostics company and provider of BREVAGen plus ®, a first-in-class, clinically validated risk assessment test for sporadic ...


Genetic Technologies Limited: Update on Strategic Alliance
Posted on Monday February 12, 2018

MELBOURNE, Australia, Feb. 12, 2018-- Genetic Technologies Limited, wishes to advise that the Company is presently in discussions with the ASX regarding the possible application of ASX Listing Rule 11.1; ...


Change of Chief Executive Officer
Posted on Tuesday February 06, 2018

MELBOURNE, Australia, Feb. 06, 2018-- Genetic Technologies Limited, advises that the Board and Mr Eutillio Buccilli have today agreed that Mr Buccilli step down as Chief Executive Officer with immediate ...


Appointment of Chairman
Posted on Monday February 05, 2018

MELBOURNE, Australia, Feb. 05, 2018-- Genetic Technologies Limited, is pleased to announce that the Board of Directors has appointed Dr Paul A. Kasian as Chairman. This follows previous Chairman Dr Malcolm. ...


Genetic Technologies Ltd. ADR
MarketWatch - Jul 22, 2017
Genetic Technologies Ltd. ADR. Genetic Technologies Ltd. is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health.

News Genetic Technologies Ltd. ADRGENE
Wall Street Journal - Feb 12, 2011
News Genetic Technologies Ltd. ADRGENE. Significant News Only. 02/15/18; Press Release. Genetic Technologies Announces Strategic Alliance and Capital Raising.

Genetic Technologies Tanked on $6M ADS Sale (GENE)
Investopedia - Dec 2, 2016
Genetic Technologies Ltd. ADR (GENE), whose share price more than doubled on Tuesday after the company signed a license agreement with the University of Melbourne to develop and market a colorectal cancer risk assessment test, lost all its recent gains ...

Genetic Technologies (GENE) Stock: Gaining On NASDAQ Compliance
CNA Finance (press release) - Jan 9, 2018
Genetic Technologies Limited (ADR) (NASDAQ: GENE) is having an overwhelmingly strong start to the trading session this morning, and for good reason.
Genetic Technologies Regains Nasdaq Listing Compliance - Markets Insider

Enter a stock symbol to view the stock details.